Céline Dorival

8.9k total citations
28 papers, 228 citations indexed

About

Céline Dorival is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Céline Dorival has authored 28 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 21 papers in Hepatology and 4 papers in Pharmacology. Recurrent topics in Céline Dorival's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (8 papers). Céline Dorival is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (8 papers). Céline Dorival collaborates with scholars based in France, United States and Japan. Céline Dorival's co-authors include Fabrice Carrat, Stanislas Pol, Marc Bourlière, Dominique Larrey, Fabien Zoulim, Hélène Fontaine, Victor de Lédinghen, Laure Coulombel, Didier Samuel and Carole Cagnot and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Céline Dorival

26 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Céline Dorival France	8	146	145	27	26	23	28	228
Eleni Gigi Greece	11	212 1.5×	204 1.4×	38 1.4×	13 0.5×	12 0.5×	22	302
Fernanda Branco Brazil	8	165 1.1×	163 1.1×	12 0.4×	5 0.2×	29 1.3×	11	252
Toby Delahooke United Kingdom	8	208 1.4×	195 1.3×	36 1.3×	4 0.2×	43 1.9×	15	300
Dina Elhammady Egypt	8	126 0.9×	114 0.8×	44 1.6×	5 0.2×	23 1.0×	24	222
Vassilios Sevastianos Greece	7	399 2.7×	364 2.5×	16 0.6×	9 0.3×	17 0.7×	23	459
C. Hézode France	9	251 1.7×	273 1.9×	8 0.3×	22 0.8×	11 0.5×	37	309
Lóa Davíðsdóttir Sweden	8	397 2.7×	348 2.4×	32 1.2×	10 0.4×	23 1.0×	12	495
S Mauss Germany	7	216 1.5×	245 1.7×	18 0.7×	3 0.1×	30 1.3×	17	300
Mette Rye Clausen Denmark	10	121 0.8×	122 0.8×	38 1.4×	2 0.1×	28 1.2×	26	222
Rikita Hatia United States	8	254 1.7×	254 1.8×	9 0.3×	3 0.1×	32 1.4×	18	345

Countries citing papers authored by Céline Dorival

Since Specialization

Citations

This map shows the geographic impact of Céline Dorival's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Dorival with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Dorival more than expected).

Fields of papers citing papers by Céline Dorival

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Dorival. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Dorival. The network helps show where Céline Dorival may publish in the future.

Co-authorship network of co-authors of Céline Dorival

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Dorival. A scholar is included among the top collaborators of Céline Dorival based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Dorival. Céline Dorival is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barré, Tangui, Lucia Parlati, Marc Bourlière, et al.. (2024). Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather). Journal of Viral Hepatitis. 31(12). 830–846.

Barré, Tangui, Marc Bourlière, Lucia Parlati, et al.. (2023). Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort). Drug and Alcohol Review. 43(3). 718–731.

Leducq, Valentin, Karen Zafilaza, Sophie Sayon, et al.. (2023). Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies. The Journal of Infectious Diseases. 229(5). 1341–1351. 4 indexed citations

Dorival, Céline, Carole Cagnot, Hélène Fontaine, et al.. (2022). Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response. Clinics and Research in Hepatology and Gastroenterology. 46(6). 101923–101923. 14 indexed citations

Carrieri, Patrizia, Fabrice Carrat, Marc Bourlière, et al.. (2022). Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors. JHEP Reports. 4(6). 100481–100481. 6 indexed citations

Augustin, Jérémy, Céline Dorival, Fabrice Carrat, et al.. (2022). Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle. Hepatology International. 16(6). 1259–1272. 1 indexed citations

Barré, Tangui, Hélène Fontaine, Stanislas Pol, et al.. (2022). Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort). Antioxidants. 11(2). 379–379. 5 indexed citations

Fontaine, Hélène, Nathanaël Lapidus, Clovis Lusivika‐Nzinga, et al.. (2022). Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort. Journal of Viral Hepatitis. 30(3). 232–241. 4 indexed citations

Barré, Tangui, Hélène Fontaine, Stanislas Pol, et al.. (2022). Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort). Clinical Nutrition. 41(3). 610–619. 14 indexed citations

10.

Fontaine, Hélène, Nathanaël Lapidus, Céline Dorival, et al.. (2022). Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers. Journal of Hepatology. 77. S17–S18. 2 indexed citations

11.

Pol, Stanislas, Philippe Sogni, Hélène Fontaine, et al.. (2021). Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis. HIV Medicine. 22(10). 924–935. 1 indexed citations

12.

Barré, Tangui, Camélia Protopopescu, Fabienne Marcellin, et al.. (2020). Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C‐infected patients (ANRS CO22 Hepather cohort). Journal of Viral Hepatitis. 27(12). 1473–1483. 12 indexed citations

13.

Lédinghen, Victor de, Clovis Lusivika‐Nzinga, Jean–Pierre Bronowicki, et al.. (2020). Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort. Journal of Viral Hepatitis. 27(10). 964–973. 4 indexed citations

14.

Lusivika‐Nzinga, Clovis, Hélène Fontaine, Céline Dorival, et al.. (2019). The dynamic effect of direct‐acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C. Journal of Viral Hepatitis. 26(12). 1489–1492. 13 indexed citations

15.

Sultanik, Philippe, Vincent Mallet, Sylvie Lagaye, et al.. (2015). Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapy. Liver International. 35(7). 1833–1844. 5 indexed citations

16.

Laouenan, Cédric, Patrick Marcellin, Martine Lapalus, et al.. (2014). Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. Antimicrobial Agents and Chemotherapy. 58(9). 5332–5341. 7 indexed citations

17.

Laouenan, Cédric, Jérémie Guedj, Gilles Peytavin, et al.. (2014). A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy. CPT Pharmacometrics & Systems Pharmacology. 4(1). 37–40. 4 indexed citations

18.

Dorival, Céline, Jean‐Daniel Lelièvre, Nathalie Sol‐Foulon, et al.. (2008). HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursor. Virology. 377(1). 207–215. 10 indexed citations

19.

Mouly, Enguerran, Céline Dorival, Françoise Pflumio, et al.. (2006). CD4 regulation in human lymphoid non-T-cells: A role for the silencer element. Molecular Immunology. 44(4). 267–275. 2 indexed citations

20.

Lefort, Nathalie, Clarisse Benne, Jean‐Daniel Lelièvre, et al.. (2006). Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cells. Experimental Hematology. 34(12). 1720–1729. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact